GlassScriptPhysician profile
Edward A Harlamert
NPI 1790739480
$27,951.60
in general payments reported to CMS, 2019-2025
28 companies · $367 in 2025
The $367 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $280 · 2021: $423 · 2022: $2,906 · 2023: $718 · 2024: $680 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,765.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $13,454.95 | 2019-2025 | Intrasight Integrated |
| Fujifilm Healthcare Americas Corporation | $10,000.00 | 2019 | |
| Boston Scientific Corporation | $1,433.47 | 2019-2024 | Watchman Access System, Watchman Flx, Ekosonic |
| Novartis Pharmaceuticals Corporation | $610.28 | 2019-2025 | |
| Amgen INC. | $543.91 | 2019-2025 | Repatha, Repatha |
| Cardiovascular Systems INC. | $432.09 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.16 | 2019-2025 | Jardiance |
| Abbott Laboratories | $216.50 | 2019-2025 | Cardiomems, Allure, Aveir |
| E.R. Squibb & Sons, L.L.C. | $172.27 | 2019-2025 | Camzyos, Eliquis |
| Stryker Corporation | $149.20 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.40 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $108.45 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $69.42 | 2020-2024 | Farxiga |
| Kiniksa Pharmaceuticals International, Plc | $52.67 | 2024 | Arcalyst |
| Shockwave Medical, INC | $39.19 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $37.99 | 2021-2022 | |
| Altathera Pharmaceuticals LLC | $35.32 | 2023-2024 | Sotalol Hydrochloride |
| Merck Sharp & Dohme LLC | $35.03 | 2021-2023 | Verquvo |
| Avanir Pharmaceuticals, INC. | $34.13 | 2019 | |
| Pfizer INC. | $30.36 | 2019-2023 | |
| Ucb, INC. | $29.87 | 2019 | |
| Sanofi-Aventis U.S. LLC | $24.49 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.58 | 2019 | |
| Abiomed | $17.33 | 2019 | |
| Scpharmaceuticals INC. | $16.51 | 2024 | |
| Daiichi Sankyo INC. | $15.27 | 2021 | |
| Edwards Lifesciences Corporation | $15.13 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biotronik INC. | $13.63 | 2024 | Nhancer Rx, Pk Papyrus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Harlamert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.